|
🐜
|
N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
16 auth.
M. Berk,
D. Copolov,
O. Dean,
Kristy Lu,
S. Jeavons,
I. Schapkaitz,
M. Anderson-Hunt,
F. Judd,
Fiona Katz,
P. Katz,
...
S. Ording-Jespersen,
J. Little,
P. Conus,
M. Cuénod,
K. Do,
A. Bush
|
8 |
2008 |
8
🐜
|
|
🐜
|
Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients
17 auth.
S. Lavoie,
M. Murray,
P. Deppen,
M. G. Knyazeva,
M. Berk,
O. Boulat,
P. Bovet,
A. Bush,
P. Conus,
D. Copolov,
...
E. Fornari,
R. Meuli,
Alessandra Solida,
P. Vianin,
M. Cuénod,
T. Buclin,
K. Do
|
8 |
2008 |
8
🐜
|
|
🐜
|
The impact of substance use disorders on clinical outcome in 643 patients with first‐episode psychosis
9 auth.
M. Lambert,
P. Conus,
D. Lubman,
D. Wade,
H. Yuen,
S. Moritz,
...
D. Naber,
P. McGorry,
B. Schimmelmann
|
8 |
2005 |
8
🐜
|
|
🐜
|
Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence
14 auth.
R. Gysin,
R. Kraftsik,
J. Sandell,
P. Bovet,
C. Chappuis,
P. Conus,
P. Deppen,
M. Preisig,
V. Ruiz,
P. Steullet,
...
M. Tošić,
T. Werge,
M. Cuénod,
K. Do
|
8 |
2007 |
8
🐜
|
|
🐜
|
A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders
187 auth.
Flore Zufferey,
E. Sherr,
N. Beckmann,
E. Hanson,
A. Maillard,
L. Hippolyte,
A. Macé,
C. Ferrari,
Z. Kutalik,
J. Andrieux,
E. Aylward,
M. Barker,
R. Bernier,
S. Bouquillon,
P. Conus,
...
B. Delobel,
W. Faucett,
R. Goin-Kochel,
E. Grant,
L. Harewood,
J. Hunter,
S. Lebon,
D. Ledbetter,
C. Martin,
K. Männik,
D. Martinet,
P. Mukherjee,
M. Ramocki,
S. Spence,
K. Steinman,
Jennifer Tjernage,
J. Spiro,
A. Reymond,
J. Beckmann,
W. Chung,
S. Jacquemont,
M. Addor,
B. Arveiler,
M. Belfiore,
F. Béna,
L. Bernardini,
P. Blanchet,
D. Bonneau,
O. Boute,
P. Callier,
D. Campion,
J. Chiésa,
M. Cordier,
J. Cuisset,
A. David,
N. Leeuw,
B. Vries,
Gérard Didelot,
M. Doco‐Fenzy,
Bénédicte Duban Bedu,
C. Dubourg,
S. Dupuis-Girod,
C. Fagerberg,
L. Faivre,
F. Fellmann,
B. Fernandez,
R. Fisher,
E. Flori,
A. Goldenberg,
D. Heron,
M. Holder,
Juliane Hoyer,
B. Isidor,
S. Jaillard,
P. Jonveaux,
S. Joriot,
H. Journel,
R. Kooy,
C. Caignec,
B. Leheup,
M. Lemaître,
S. Lewis,
V. Malan,
M. Mathieu-Dramard,
A. Metspalu,
F. Morice-Picard,
M. Mucciolo,
E. Õiglane‐Shlik,
K. Õunap,
L. Pasquier,
F. Petit,
A. Philippe,
G. Plessis,
F. Prieur,
J. Puechberty,
E. Rajcan-Separovic,
A. Rauch,
A. Renieri,
C. Rieubland,
C. Rooryck,
K. Rötzer,
Mariken Ruiter,
D. Sanlaville,
Stéphanie Selmoni,
Yiping Shen,
V. Siffredi,
J. Thonney,
L. Vallée,
E. V. Binsbergen,
N. Aa,
M. Haelst,
J. Vigneron,
C. Vincent-Delorme,
Disciglio Vittoria,
A. V. Silfhout,
R. Witwicki,
S. Zwolinski,
Alexandra Bowe,
A. Beaudet,
Christie M. Brewton,
Z. Chu,
Allison G. Dempsey,
Yolanda L. Evans,
Silvia Garza,
S. Kanne,
A. Laakman,
Morgan W. Lasala,
Ashlie V. Llorens,
Gabriela Marzano,
T. J. Moss,
Kerri P. Nowell,
M. Proud,
Qixuan Chen,
R. Vaughan,
J. Berman,
L. Blaskey,
Katherine Hines,
S. Kessler,
Sarah Y. Khan,
S. Qasmieh,
Audrey L. Bibb,
A. Paal,
Patricia Z. Page,
Bethanny Smith‐Packard,
R. Buckner,
Jordan Burko,
A. Cavanagh,
Bettina M. Cerban,
Anne V. Snow,
L. Snyder,
R. M. Keehn,
David T. Miller,
Fiona A. Miller,
J. Olson,
Christina Triantafallou,
N. Visyak,
Constance W. Atwell,
Marta Benedetti,
Gerald Fischbach,
M. Greenup,
A. Packer,
Polina Bukshpun,
Maxwell Cheong,
C. Dale,
Sarah E. Gobuty,
L. Hinkley,
R. Jeremy,
Hana Lee,
T. Luks,
E. Marco,
Alastair Martin,
Kathleen E. McGovern,
S. Nagarajan,
J. Owen,
B. Paul,
Nicholas Pojman,
Tuhin K. Sinha,
V. Swarnakar,
Mari Wakahiro,
Hanalore Alupay,
Benjamin Aaronson,
S. Ackerman,
K. Ankenman,
J. Elgin,
J. Gerdts,
Kelly Johnson,
Beau Reilly,
Dennis Shaw,
Arianne D. Stevens,
Tracey Ward,
Julia Wenegrat,
T. Roberts
|
8 |
2012 |
8
🐜
|
|
🐜
|
Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence
8 auth.
M. Lambert,
P. Conus,
P. Eide,
R. Mass,
A. Karow,
S. Moritz,
...
D. Golks,
D. Naber
|
8 |
2004 |
8
🐜
|
|
🐜
|
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
12 auth.
M. Yücel,
E. Bora,
D. Lubman,
N. Solowij,
W. Brewer,
S. Cotton,
...
P. Conus,
Michael Takagi,
A. Fornito,
S. Wood,
P. McGorry,
C. Pantelis
|
7 |
2012 |
7
🐜
|
|
🐜
|
Setting the stage: from prodrome to treatment resistance in bipolar disorder.
9 auth.
M. Berk,
P. Conus,
N. Lucas,
K. Hallam,
G. Malhi,
S. Dodd,
...
L. Yatham,
A. Yung,
P. McGorry
|
7 |
2007 |
7
🐜
|
|
🐜
|
Defining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical Comorbidities.
55 auth.
Deb D'Angelo,
S. Lebon,
Qixuan Chen,
S. Martin-Brevet,
L. Snyder,
L. Hippolyte,
E. Hanson,
A. Maillard,
W. Faucett,
A. Macé,
A. Pain,
R. Bernier,
S. Chawner,
A. David,
J. Andrieux,
...
E. Aylward,
G. Baujat,
Inês Caldeira,
P. Conus,
C. Ferrari,
F. Forzano,
M. Gérard,
R. Goin-Kochel,
E. Grant,
J. Hunter,
B. Isidor,
Ken Porche,
A. Jacquette,
A. Jønch,
B. Keren,
D. Lacombe,
C. Le Caignec,
C. Martin,
K. Männik,
A. Metspalu,
C. Mignot,
P. Mukherjee,
M. Owen,
M. Passeggeri,
C. Rooryck-Thambo,
J. Rosenfeld,
S. Spence,
K. Steinman,
Jennifer Tjernagel,
Mieke van Haelst,
Yiping Shen,
Bogdan Draganski,
E. Sherr,
D. Ledbetter,
M. V. D. van den Bree,
J. Beckmann,
J. Spiro,
A. Reymond,
S. Jacquemont,
W. Chung
|
7 |
2016 |
7
🐜
|
|
🐬
|
Developing psychosis and its risk states through the lens of schizotypy.
M. Debbané,
S. Eliez,
Deborah Badoud,
P. Conus,
R. Flückiger,
F. Schultze-Lutter
|
7 |
2015 |
7
🐬
|
|
🐢
|
Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis
7 auth.
S. Cotton,
M. Lambert,
B. G. Schimmelmann,
Debra L. Foley,
Katherine I. Morley,
P. McGorry,
...
P. Conus
|
7 |
2008 |
7
🐢
|
